Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Intervertebral disc protrusion? 161 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Intervertebral disc protrusion have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.1% of all adverse event reports for LENALIDOMIDE.

161
Reports of Intervertebral disc protrusion with LENALIDOMIDE
0.1%
of all LENALIDOMIDE reports
0
Deaths
50
Hospitalizations

How Dangerous Is Intervertebral disc protrusion From LENALIDOMIDE?

Of the 161 reports, 50 (31.1%) required hospitalization, and 2 (1.2%) were considered life-threatening.

Is Intervertebral disc protrusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 161 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Intervertebral disc protrusion?

ADALIMUMAB (2,760) ETANERCEPT (751) METHOTREXATE (648) SODIUM OXYBATE (427) PREGABALIN (415) TOFACITINIB (393) UPADACITINIB (384) INTERFERON BETA-1A (295) PREDNISONE (285) SECUKINUMAB (268)

Which LENALIDOMIDE Alternatives Have Lower Intervertebral disc protrusion Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Intervertebral disc protrusion Reports All Drugs Causing Intervertebral disc protrusion LENALIDOMIDE Demographics